Fang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fang Wang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Xiankun Sun
Department of Nephrology West China Hospital, Sichuan University/West China School of Nursing, Sichuan University Chengdu Sichuan China
5 shared publications Zhiwen Chen
Department of Nephrology West China Hospital, Sichuan University/West China School of Nursing, Sichuan University Chengdu Sichuan China
5 shared publicationsLi Lin
Department of Nephrology West China Hospital, Sichuan University/West China School of Nursing, Sichuan University Chengdu Sichuan China
4 shared publicationsLing Zhang
Department of Nephrology and Kidney Research Institute West China Hospital, Sichuan University Chengdu Sichuan China
4 shared publicationsXue Tang
Department of Nephrology West China Hospital, Sichuan University/West China School of Nursing, Sichuan University Chengdu Sichuan China
4 shared publications- Ling Zhang
Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University
3 shared publications
Latest Publications
- Open Access
- 31 July 2026
- Published by Wiley in Seminars in Dialysis
- Vol. 39 (4) , 177-184
Antimicrobial Glucose Chlorhexidine Dressings vs. Sterile Dressings in Preventing Catheter‐Related Infections During Continuous Renal Replacement Therapy: A Randomized Controlled Trial
Background: Catheter‐related bloodstream infections (CRBSIs) are a major cause of complications in critically ill patients receiving continuous renal replacement therapy (CRRT), especially those with nontunneled catheters. These infections can lead to longer hospital stays, higher costs, and worse patient outcomes. Although sterile dressings are commonly used to prevent CRBSIs, antimicrobial dressings, such as those containing chlorhexidine, may offer better protection. This study aimed to compare the effectiveness of antimicrobial glucose chlorhexidine dressings and sterile dressings in preventing CRBSIs in patients receiving CRRT. Methods: A prospective, randomized controlled, single‐blind study was conducted. All participants were kept blinded to group assignment. We enrolled patients admitted to the Intensive Care Unit (ICU) of West China Hospital, Sichuan University between September 2022 and November 2023 who were scheduled for vascular catheter placement before receiving continuous renal replacement therapy (CRRT). The participants were randomly allocated to either the intervention group (receiving glucose chlorhexidine antimicrobial dressing) or the control group (receiving sterile dressing) via a random number table. The dressing was changed every 7 days for the glucose chlorhexidine antimicrobial group and every 48 h for the sterile dressing group, in accordance with the guideline. Dressings were replaced immediately if they became rolled, loose, or visibly soiled. The primary outcomes were the local infection rate at the catheter insertion site, suspected catheter‐related bloodstream infections (CRBSIs), incidence of CRBSIs, length of hospital stay, ICU stay duration, and hospital mortality rates. Results: A total of 520 patients were screened, and 410 patients were ultimately included in the study, with 205 patients in each group (glucose chlorhexidine antimicrobial dressing group and sterile dressing group). The incidence of local infection at the catheter insertion site was 40.0% in the sterile dressing group, which was significantly greater than the 15.6% reported in the glucose chlorhexidine antimicrobial dressing group ( p < 0.001). The total CRBSI rate in the intervention group was significantly lower (6.3%) than that in the control group (13.7%) ( p = 0.014). No significant differences were found between the two groups in terms of suspected catheter‐related bloodstream infections (CRBSIs), CRBSI incidence, length of hospital stay, ICU stay duration, or hospital mortality rates ( p > 0.05). The Cox proportional hazards model suggested that patients in the control group were at a substantially greater risk of local infections and CRBSIs over time than those in the intervention group. Conclusion: Glucose chlorhexidine antimicrobial dressings significantly reduce catheter insertion site infections and overall CRBSI incidence, demonstrating their clinical value in preventing infection in patients receiving CRRT.
- 31 July 2026
- Published by Wiley in Seminars in Dialysis
- Vol. 39 (4) , 177-184
Open AccessAntimicrobial Glucose Chlorhexidine Dressings vs. Sterile Dressings in Preventing Catheter‐Related Infections During Continuous Renal Replacement Therapy: A Randomized Controlled Trial
Background: Catheter‐related bloodstream infections (CRBSIs) are a major cause of complications in critically ill patients receiving continuous renal replacement therapy (CRRT), especially those with nontunneled catheters. These infections can lead to longer hospital stays, higher costs, and worse patient outcomes. Although sterile dressings are commonly used to prevent CRBSIs, antimicrobial dressings, such as those containing chlorhexidine, may offer better protection. This study aimed to compare the effectiveness of antimicrobial glucose chlorhexidine dressings and sterile dressings in preventing CRBSIs in patients receiving CRRT. Methods: A prospective, randomized controlled, single‐blind study was conducted. All participants were kept blinded to group assignment. We enrolled patients admitted to the Intensive Care Unit (ICU) of West China Hospital, Sichuan University between September 2022 and November 2023 who were scheduled for vascular catheter placement before receiving continuous renal replacement therapy (CRRT). The participants were randomly allocated to either the intervention group (receiving glucose chlorhexidine antimicrobial dressing) or the control group (receiving sterile dressing) via a random number table. The dressing was changed every 7 days for the glucose chlorhexidine antimicrobial group and every 48 h for the sterile dressing group, in accordance with the guideline. Dressings were replaced immediately if they became rolled, loose, or visibly soiled. The primary outcomes were the local infection rate at the catheter insertion site, suspected catheter‐related bloodstream infections (CRBSIs), incidence of CRBSIs, length of hospital stay, ICU stay duration, and hospital mortality rates. Results: A total of 520 patients were screened, and 410 patients were ultimately included in the study, with 205 patients in each group (glucose chlorhexidine antimicrobial dressing group and sterile dressing group). The incidence of local infection at the catheter insertion site was 40.0% in the sterile dressing group, which was significantly greater than the 15.6% reported in the glucose chlorhexidine antimicrobial dressing group ( p < 0.001). The total CRBSI rate in the intervention group was significantly lower (6.3%) than that in the control group (13.7%) ( p = 0.014). No significant differences were found between the two groups in terms of suspected catheter‐related bloodstream infections (CRBSIs), CRBSI incidence, length of hospital stay, ICU stay duration, or hospital mortality rates ( p > 0.05). The Cox proportional hazards model suggested that patients in the control group were at a substantially greater risk of local infections and CRBSIs over time than those in the intervention group. Conclusion: Glucose chlorhexidine antimicrobial dressings significantly reduce catheter insertion site infections and overall CRBSI incidence, demonstrating their clinical value in preventing infection in patients receiving CRRT.
- 9 April 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (2) , e70121
Double Plasma Molecular Adsorption System Plus Sequential Half‐Dose Plasmapheresis in Tandem With Continuous Renal Replacement Therapy: A Case Report
A 48‐year‐old male patient was diagnosed with critical acute pancreatitis, renal dysfunction and liver dysfunction. Because of the presence of multiorgan dysfunction, continuous renal replacement therapy (CRRT) was required on the first day of the patient's admission to the ICU in order to help stabilize the patient's internal environment. Meanwhile, the patient also received a total of five double plasma molecular adsorption system plus sequential half‐dose plasmapheresis (DPMAS‐PE) treatments, of which the first, fourth, and fifth DPMAS‐PE treatments were chosen to be administered concurrently with CRRT. This report is to clarify how four CRRT machines using three parallel modalities successfully completed DPMAS‐PE in tandem with CRRT (DPMAS‐PE‐CRRT). Furthermore, DPMAS‐PE‐CRRT showed similar effectiveness in removing total bilirubin and total bile acid when compared to nonparallel CRRT. During the parallel therapy, there were no serious adverse reactions. To validate this case, more clinical trials are needed.
- 9 April 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (2) , e70121
Double Plasma Molecular Adsorption System Plus Sequential Half‐Dose Plasmapheresis in Tandem With Continuous Renal Replacement Therapy: A Case Report
A 48‐year‐old male patient was diagnosed with critical acute pancreatitis, renal dysfunction and liver dysfunction. Because of the presence of multiorgan dysfunction, continuous renal replacement therapy (CRRT) was required on the first day of the patient's admission to the ICU in order to help stabilize the patient's internal environment. Meanwhile, the patient also received a total of five double plasma molecular adsorption system plus sequential half‐dose plasmapheresis (DPMAS‐PE) treatments, of which the first, fourth, and fifth DPMAS‐PE treatments were chosen to be administered concurrently with CRRT. This report is to clarify how four CRRT machines using three parallel modalities successfully completed DPMAS‐PE in tandem with CRRT (DPMAS‐PE‐CRRT). Furthermore, DPMAS‐PE‐CRRT showed similar effectiveness in removing total bilirubin and total bile acid when compared to nonparallel CRRT. During the parallel therapy, there were no serious adverse reactions. To validate this case, more clinical trials are needed.
- 10 April 2025
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 40 (2) , e70019
Efficacy and Safety of Double Plasma Molecular Adsorption System at Different Therapeutic Doses During Regional Citrate Anticoagulation: A Pilot Study
This study aimed to assess the safety and therapeutic efficacy of increasing the dosage of the double plasma molecular adsorption system (DPMAS) in patients with liver failure during regional citrate anticoagulation (RCA). A prospective nonrandomized controlled trial was conducted. Three groups (3 L group, 4.5 L group, and 6 L group) of patients with liver failure receiving DPMAS treatment were created on the basis of various therapeutic plasma volumes. A total of 303 patients were included, with 110 in the 3 L group, 121 in the 4.5 L group, and 72 in the 6 L group. At the end of treatment, there was a statistically significant difference in the bilirubin clearance rate among the groups (H = 15.239, p < 0.001). Pairwise comparisons revealed that only the difference in the bilirubin clearance rates between the 6 L group and the 3 L group was statistically significant (p < 0.001). With the exception of base excess, no statistically significant differences were found between these three groups for any of the relevant laboratory indicators (p > 0.05). The incidence of hypotension, hypocalcemia, acidosis, alkalosis, hypernatremia, hyperlactatemia, and allergic reactions did not differ significantly among these three groups (p > 0.05). Furthermore, a statistically significant difference was found in clotting events among these three groups (p = 0.027), with a higher incidence observed in the 6 L group than in the 3 L group (p = 0.011). Increasing the therapeutic dose of RCA‐DPMAS further removed bilirubin and did not increase the complications associated with citrate anticoagulation, but the coagulation risk is a concern.
- 10 April 2025
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 40 (2) , e70019
Efficacy and Safety of Double Plasma Molecular Adsorption System at Different Therapeutic Doses During Regional Citrate Anticoagulation: A Pilot Study
This study aimed to assess the safety and therapeutic efficacy of increasing the dosage of the double plasma molecular adsorption system (DPMAS) in patients with liver failure during regional citrate anticoagulation (RCA). A prospective nonrandomized controlled trial was conducted. Three groups (3 L group, 4.5 L group, and 6 L group) of patients with liver failure receiving DPMAS treatment were created on the basis of various therapeutic plasma volumes. A total of 303 patients were included, with 110 in the 3 L group, 121 in the 4.5 L group, and 72 in the 6 L group. At the end of treatment, there was a statistically significant difference in the bilirubin clearance rate among the groups (H = 15.239, p < 0.001). Pairwise comparisons revealed that only the difference in the bilirubin clearance rates between the 6 L group and the 3 L group was statistically significant (p < 0.001). With the exception of base excess, no statistically significant differences were found between these three groups for any of the relevant laboratory indicators (p > 0.05). The incidence of hypotension, hypocalcemia, acidosis, alkalosis, hypernatremia, hyperlactatemia, and allergic reactions did not differ significantly among these three groups (p > 0.05). Furthermore, a statistically significant difference was found in clotting events among these three groups (p = 0.027), with a higher incidence observed in the 6 L group than in the 3 L group (p = 0.011). Increasing the therapeutic dose of RCA‐DPMAS further removed bilirubin and did not increase the complications associated with citrate anticoagulation, but the coagulation risk is a concern.
- 7 April 2025
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 40 (2) , e70021
Efficacy and Safety of Using Designed Auxiliary Lines in Standard CRRT Machines for DFPP Treatment
The demand for double‐filtration plasmapheresis (DFPP) in clinical settings is growing steadily, yet the range and availability of specialized equipment designed to support DFPP are relatively limited. We aimed to assess the efficacy and safety of a designed auxiliary line for DFPP treatment using standard continuous renal replacement treatment (CRRT) machines. This prospective self‐controlled study was conducted between May 2021 and April 2024. Patients who underwent DFPP treatment using both specialized DFPP machines and standard CRRT machines (using designed auxiliary line) were enrolled in the study. DFPP sessions were divided into the specialized DFPP machine group and the standard CRRT machine group. The rates of completed DFPP treatments, DFPP cost, circuit clotting, hypotension, anaphylaxis, hypocalcemia, and nurse operating time were compared. A total of 440 DFPP sessions were performed for 80 patients, with 330 (75.0%) sessions in the specialized DFPP machine group and 110 (25.0%) in the standard CRRT machine group. There were no statistically significant differences between the two groups in terms of the completed DFPP treatment rate (89.4% vs. 88.2%, p = 0.724), circuit clotting (8.2% vs. 7.3%, p = 0.760), anaphylaxis (12.7% vs. 11.8%, p = 0.803), hypotension (10.6% vs. 9.1%, p = 0.650), hypocalcemia (17.3% vs. 20.0%, p = 0.519), and nurse operation time (35.08 ± 2.27 min vs. 36.62 ± 1.94 min, p = 0.082). However, the cost per DFPP session in the standard CRRT machine group was lower than in the specialized DFPP machine (976.81 ± 14.38 $ vs. 1007.43 ± 35.30 $, p < 0.001). Standard CRRT machines can effectively and safely perform DFPP treatment using a specially designed auxiliary line, which is more cost‐effective. Even in primary hospitals without specialized DFPP machines, CRRT machines can be used to perform DFPP treatment.- 7 April 2025
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 40 (2) , e70021
Efficacy and Safety of Using Designed Auxiliary Lines in Standard CRRT Machines for DFPP Treatment
The demand for double‐filtration plasmapheresis (DFPP) in clinical settings is growing steadily, yet the range and availability of specialized equipment designed to support DFPP are relatively limited. We aimed to assess the efficacy and safety of a designed auxiliary line for DFPP treatment using standard continuous renal replacement treatment (CRRT) machines. This prospective self‐controlled study was conducted between May 2021 and April 2024. Patients who underwent DFPP treatment using both specialized DFPP machines and standard CRRT machines (using designed auxiliary line) were enrolled in the study. DFPP sessions were divided into the specialized DFPP machine group and the standard CRRT machine group. The rates of completed DFPP treatments, DFPP cost, circuit clotting, hypotension, anaphylaxis, hypocalcemia, and nurse operating time were compared. A total of 440 DFPP sessions were performed for 80 patients, with 330 (75.0%) sessions in the specialized DFPP machine group and 110 (25.0%) in the standard CRRT machine group. There were no statistically significant differences between the two groups in terms of the completed DFPP treatment rate (89.4% vs. 88.2%, p = 0.724), circuit clotting (8.2% vs. 7.3%, p = 0.760), anaphylaxis (12.7% vs. 11.8%, p = 0.803), hypotension (10.6% vs. 9.1%, p = 0.650), hypocalcemia (17.3% vs. 20.0%, p = 0.519), and nurse operation time (35.08 ± 2.27 min vs. 36.62 ± 1.94 min, p = 0.082). However, the cost per DFPP session in the standard CRRT machine group was lower than in the specialized DFPP machine (976.81 ± 14.38 $ vs. 1007.43 ± 35.30 $, p < 0.001). Standard CRRT machines can effectively and safely perform DFPP treatment using a specially designed auxiliary line, which is more cost‐effective. Even in primary hospitals without specialized DFPP machines, CRRT machines can be used to perform DFPP treatment.- 21 August 2024
- Published by Wiley in Seminars in Dialysis
- Vol. 37 (6) , 466-470
Continuous Renal Replacement Therapy Needs Its Own Circuit Diagram
- 21 August 2024
- Published by Wiley in Seminars in Dialysis
- Vol. 37 (6) , 466-470
Continuous Renal Replacement Therapy Needs Its Own Circuit Diagram
- Open Access
- 20 February 2023
- Published by Wiley in Seminars in Dialysis
- Vol. 37 (1) , 52-58
An evaluation of different dilution modes on circuit lifespan during continuous veno‐venous hemodiafiltration without anticoagulation
Background: Circuit clotting remains a major problem during continuous kidney replacement therapy (CKRT), particularly in patients with contraindications to anticoagulant use. We hypothesized that the different options of alternative replacement fluid infusion sites might affect circuit lifespan. However, research‐based evidence supporting an optimal replacement fluid infusion strategy is limited. Therefore, we aimed to evaluate the effect of three dilution modes (pre‐dilution, post‐dilution, and pre‐ to post‐dilution) on circuit lifespan during continuous veno‐venous hemodiafiltration (CVVHDF).Methods: This prospective cohort study was conducted between December 2019 and December 2020. Patients requiring CKRT were enrolled to receive pre‐dilution, post‐dilution, or pre‐ to post‐dilution fluid infusion with CVVHDF. The primary endpoint was circuit lifespan, and the secondary outcomes included the clinical parameters of patients, such as changes in serum creatinine (Scr) and blood urea nitrogen (BUN) levels, 28‐day all‐cause mortality, and length of stay. For all patients included in this study, only the first circuit used was recorded.Results: Among the 132 patients enrolled in this study, 40 were in the pre‐dilution mode, 42 were in the post‐dilution mode, and 50 were in the pre‐ to post‐dilution mode. The mean circuit lifespan was significantly longer in the pre‐ to post‐dilution group (45.72 h, 95% CI, 39.75–51.69 h) than in the pre‐dilution group (31.58 h, 95% CI, 26.33–36.82 h) and the post‐dilution group (35.20 h, 95% CI, 29.62–40.78 h). There was no significant difference between the pre‐ and post‐dilution group circuit lifespan (p > 0.05). Kaplan–Meier survival analysis revealed a significant difference between the three dilution modes (p = 0.001). No significant differences were observed in terms of changes in the Scr and BUN levels, admission day, and 28‐day all‐cause mortality among the three dilution groups (p > 0.05).Conclusion: The pre‐ to post‐dilution mode significantly prolonged circuit lifespan but did not reduce Scr and BUN levels, compared with the pre‐dilution and post‐dilution modes during CVVHDF when no anticoagulants were used.
- 20 February 2023
- Published by Wiley in Seminars in Dialysis
- Vol. 37 (1) , 52-58
Open AccessAn evaluation of different dilution modes on circuit lifespan during continuous veno‐venous hemodiafiltration without anticoagulation
Background: Circuit clotting remains a major problem during continuous kidney replacement therapy (CKRT), particularly in patients with contraindications to anticoagulant use. We hypothesized that the different options of alternative replacement fluid infusion sites might affect circuit lifespan. However, research‐based evidence supporting an optimal replacement fluid infusion strategy is limited. Therefore, we aimed to evaluate the effect of three dilution modes (pre‐dilution, post‐dilution, and pre‐ to post‐dilution) on circuit lifespan during continuous veno‐venous hemodiafiltration (CVVHDF).Methods: This prospective cohort study was conducted between December 2019 and December 2020. Patients requiring CKRT were enrolled to receive pre‐dilution, post‐dilution, or pre‐ to post‐dilution fluid infusion with CVVHDF. The primary endpoint was circuit lifespan, and the secondary outcomes included the clinical parameters of patients, such as changes in serum creatinine (Scr) and blood urea nitrogen (BUN) levels, 28‐day all‐cause mortality, and length of stay. For all patients included in this study, only the first circuit used was recorded.Results: Among the 132 patients enrolled in this study, 40 were in the pre‐dilution mode, 42 were in the post‐dilution mode, and 50 were in the pre‐ to post‐dilution mode. The mean circuit lifespan was significantly longer in the pre‐ to post‐dilution group (45.72 h, 95% CI, 39.75–51.69 h) than in the pre‐dilution group (31.58 h, 95% CI, 26.33–36.82 h) and the post‐dilution group (35.20 h, 95% CI, 29.62–40.78 h). There was no significant difference between the pre‐ and post‐dilution group circuit lifespan (p > 0.05). Kaplan–Meier survival analysis revealed a significant difference between the three dilution modes (p = 0.001). No significant differences were observed in terms of changes in the Scr and BUN levels, admission day, and 28‐day all‐cause mortality among the three dilution groups (p > 0.05).Conclusion: The pre‐ to post‐dilution mode significantly prolonged circuit lifespan but did not reduce Scr and BUN levels, compared with the pre‐dilution and post‐dilution modes during CVVHDF when no anticoagulants were used.
- Open Access
- 11 August 2021
- Published by Wiley in Nursing in Critical Care
- Vol. 27 (5) , 646-651
Reliability of monitoring acid‐base and electrolyte parameters through circuit lines during regional citrate anticoagulation‐continuous renal replacement therapy
Background The current practice involves blood sampling from the circuit line to measure acid-base and electrolyte parameters during continuous renal replacement therapy (CRRT). However, there is limited evidence supporting its reliability due to the effects of anticoagulant mechanism and access recirculation associated with regional citrate anticoagulation (RCA). Aim To evaluate the reliability of monitoring acid-base and electrolyte parameters through circuit lines in regular and reversed connections during RCA-CRRT. Study design In this prospective cohort study, we included critically ill patients receiving RCA-CRRT via a double-lumen catheter. During the second hour after CRRT initiation, we collected blood samples to monitor acid-base and electrolyte parameters and their levels were compared between samples from the circuit lines (at 0, 3, and 5 minutes) and those from the central venous catheter (CVC) line (at 0 minute). During this time, CRRT switched to the replacement state as controls. Results We observed 128 CRRT circuits in 60 adult patients receiving RCA-CRRT. Ninety-eight (76.6%) circuits had regular connections, while 30 (23.4%) had reversed connections. Among regular connections, no differences were observed in any acid-base or electrolyte parameters between samples from the CVC line and those from the circuit line at all time points (P > .05). Among reversed connections, ionized calcium levels were dramatically decreased at all three time points in samples from the circuit line compared with those from the CVC line (0.65 ± 0.12, 0.72 ± 0.11, and 0.78 ± 0.99 vs 0.98 ± 0.07 mmol/L, P < .001), with comparable levels of other acid-base or electrolyte parameters between the sampling patterns (P > .05). Conclusions Acid-base and electrolyte parameters could be reliably monitored through the circuit line during RCA-CRRT in regular connections. However, in reversed connections, pre-filter ionized calcium concentrations determined through the circuit line were lower than those determined through the CVC line. Relevance to clinical practice We suggest sampling from arterial or CVC lines rather than from the circuit line in a reversed connection during RCA-CRRT.
- 11 August 2021
- Published by Wiley in Nursing in Critical Care
- Vol. 27 (5) , 646-651
Open AccessReliability of monitoring acid‐base and electrolyte parameters through circuit lines during regional citrate anticoagulation‐continuous renal replacement therapy
Background The current practice involves blood sampling from the circuit line to measure acid-base and electrolyte parameters during continuous renal replacement therapy (CRRT). However, there is limited evidence supporting its reliability due to the effects of anticoagulant mechanism and access recirculation associated with regional citrate anticoagulation (RCA). Aim To evaluate the reliability of monitoring acid-base and electrolyte parameters through circuit lines in regular and reversed connections during RCA-CRRT. Study design In this prospective cohort study, we included critically ill patients receiving RCA-CRRT via a double-lumen catheter. During the second hour after CRRT initiation, we collected blood samples to monitor acid-base and electrolyte parameters and their levels were compared between samples from the circuit lines (at 0, 3, and 5 minutes) and those from the central venous catheter (CVC) line (at 0 minute). During this time, CRRT switched to the replacement state as controls. Results We observed 128 CRRT circuits in 60 adult patients receiving RCA-CRRT. Ninety-eight (76.6%) circuits had regular connections, while 30 (23.4%) had reversed connections. Among regular connections, no differences were observed in any acid-base or electrolyte parameters between samples from the CVC line and those from the circuit line at all time points (P > .05). Among reversed connections, ionized calcium levels were dramatically decreased at all three time points in samples from the circuit line compared with those from the CVC line (0.65 ± 0.12, 0.72 ± 0.11, and 0.78 ± 0.99 vs 0.98 ± 0.07 mmol/L, P < .001), with comparable levels of other acid-base or electrolyte parameters between the sampling patterns (P > .05). Conclusions Acid-base and electrolyte parameters could be reliably monitored through the circuit line during RCA-CRRT in regular connections. However, in reversed connections, pre-filter ionized calcium concentrations determined through the circuit line were lower than those determined through the CVC line. Relevance to clinical practice We suggest sampling from arterial or CVC lines rather than from the circuit line in a reversed connection during RCA-CRRT.
- Open Access
- 10 March 2021
- Published by Wiley in Nursing Open
- Vol. 8 (5) , 2743-2749
Reproductive concerns and associated factors among female chronic kidney diseases patients: a Multi‐Center Cross‐Sectional Study
Aim: The study aimed to investigate the current status of reproductive concerns and explore the associated factors among young female chronic kidney disease (CKD) patients.Design: A multi‐center cross‐sectional study was designed.Methods: The study was conducted in six representative tertiary hospitals across southwest China. A total of 295 female Chronic kidney disease patients between 18–45 years of age completed a 20 min, web‐based survey, which included demographics and disease‐related information questionnaire, Reproductive Concerns Scale, Generalized Anxiety Disorder 7 (GAD‐7) instrument and Patient Health Questionnaire 9 (PHQ‐9) instrument.Result: The survey total collected 270 valid questionnaires. The mean reproductive concern score was 54.39 ± 10.90 (out of a maximum of 90), with the mean scores for sub‐scales ranging from 7.80 ± 1.69 to 10.44 ± 1.85. Multiple regression analysis showed that those with higher reproductive concerns were more likely to have pregnancy intentions, to be in Chronic kidney disease stages 1–3, and to have a higher GAD‐7 score. This study offered further evidence of the need for improved education and emotional support surrounding reproductive concerns among young Chinese women with Chronic kidney disease.
- 10 March 2021
- Published by Wiley in Nursing Open
- Vol. 8 (5) , 2743-2749
Open AccessReproductive concerns and associated factors among female chronic kidney diseases patients: a Multi‐Center Cross‐Sectional Study
Aim: The study aimed to investigate the current status of reproductive concerns and explore the associated factors among young female chronic kidney disease (CKD) patients.Design: A multi‐center cross‐sectional study was designed.Methods: The study was conducted in six representative tertiary hospitals across southwest China. A total of 295 female Chronic kidney disease patients between 18–45 years of age completed a 20 min, web‐based survey, which included demographics and disease‐related information questionnaire, Reproductive Concerns Scale, Generalized Anxiety Disorder 7 (GAD‐7) instrument and Patient Health Questionnaire 9 (PHQ‐9) instrument.Result: The survey total collected 270 valid questionnaires. The mean reproductive concern score was 54.39 ± 10.90 (out of a maximum of 90), with the mean scores for sub‐scales ranging from 7.80 ± 1.69 to 10.44 ± 1.85. Multiple regression analysis showed that those with higher reproductive concerns were more likely to have pregnancy intentions, to be in Chronic kidney disease stages 1–3, and to have a higher GAD‐7 score. This study offered further evidence of the need for improved education and emotional support surrounding reproductive concerns among young Chinese women with Chronic kidney disease.